Chennai Meenakshi Multispeciality Hospital Ltd vs Shree Pacetronix Ltd Stock Comparison
Chennai Meenakshi Multispeciality Hospital Ltd vs Shree Pacetronix Ltd Stock Comparison
Last Updated on: Nov 01, 2026
Key Highlights
The Latest Trading Price of Chennai Meenakshi Multispeciality Hospital Ltd is ₹ 33.15 as of 30 Oct 15:30
. The P/E Ratio of Chennai Meenakshi Multispeciality Hospital Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Shree Pacetronix Ltd changed from 77.1 on March 2021 to 10.9 on March 2026 . This represents a CAGR of -27.82% over 6 years The Market Cap of Chennai Meenakshi Multispeciality Hospital Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Shree Pacetronix Ltd changed from ₹ 4.16 crore on March 2021 to ₹ 34.33 crore on March 2026 . This represents a CAGR of 42.16% over 6 years The revenue of Chennai Meenakshi Multispeciality Hospital Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Shree Pacetronix Ltd for the Jun '26 is ₹ 4.92 crore as compare to the Mar '26 revenue of ₹ 5.41 crore. This represent the decline of -9.06% The ebitda of Chennai Meenakshi Multispeciality Hospital Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Shree Pacetronix Ltd for the Jun '26 is ₹ 1.21 crore as compare to the Mar '26 ebitda of ₹ 1.68 crore. This represent the decline of -27.98% The net profit of Chennai Meenakshi Multispeciality Hospital Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0%
The net profit of Shree Pacetronix Ltd changed from ₹ 0.37 crore to ₹ 0.76 crore over 9 quarters. This represents a CAGR of 37.70%
The Dividend Payout of Chennai Meenakshi Multispeciality Hospital Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Shree Pacetronix Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .
About Chennai Meenakshi Multispeciality Hospital Ltd
Chennai Meenakshi Multispeciality Hospital Limited, formerly known as Devaki Hospital Limited, was incorporated in 1990.
The Company name was changed from Devaki Hospital Limited to Chennai Meenakshi Multispeciality Hospital Limited in October, 2007.
It is a 100-bedded hospital located in the heart of Chennai at Mylapore.
The hospital has an infrastructure comprising of around 105 Beds including ICU Beds, Operating Theatre, a modern dialysis Unit besides a host of other facilities.
The Company has a pool of talented and experienced doctors who are further supported by a team of highly qualified and experienced and dedicated support staff and cutting edge technology.
The Company operate into various departments like Cardiology Department; Casualty Department; Diagnostic Services; Intensive Care Unit; Nephrology Department and Physiotherapy Department.
About Shree Pacetronix Ltd
Shree Pacetronix Limited, a leading manufacturer / exporter of Pacemakers, was incorporated in January 1988 as a Private Limited Company and converted into a Public Limited Company in 1993.
It has a plant at Pithampur, Madhya Pradesh with installed capacity to produce 4800 pacemakers per annum.
Pacemakers are used to treat patients suffering mainly from heart conditions, such as heart failure and arrhythmias.
These devices are implanted under patient's chest by cardiologist to deal with various indications and used for the treatment of heart medical conditions.
Innovations such as longer-lasting batteries, advanced remote monitoring capabilities, and next-generation leadless and MRI-safe pacemakers are key pillars of the R&D agenda.
These developments not only improve clinical outcomes but also align with evolving patient needs and healthcare provider expectations, allowing to maintain a competitive edge in the rapidly advancing pacemaker industry.
FAQs for the comparison of Chennai Meenakshi Multispeciality Hospital Ltd and Shree Pacetronix Ltd
Which company has a larger market capitalization, Chennai Meenakshi Multispeciality Hospital Ltd or Shree Pacetronix Ltd?
Market cap of Chennai Meenakshi Multispeciality Hospital Ltd is 24 Cr while Market cap of Shree Pacetronix Ltd is 63 Cr
What are the key factors driving the stock performance of Chennai Meenakshi Multispeciality Hospital Ltd and Shree Pacetronix Ltd?
The stock performance of Chennai Meenakshi Multispeciality Hospital Ltd and Shree Pacetronix Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Chennai Meenakshi Multispeciality Hospital Ltd and Shree Pacetronix Ltd?
As of November 1, 2026, the Chennai Meenakshi Multispeciality Hospital Ltd stock price is INR ₹33.15. On the other hand, Shree Pacetronix Ltd stock price is INR ₹169.0.
How do dividend payouts of Chennai Meenakshi Multispeciality Hospital Ltd and Shree Pacetronix Ltd compare?
To compare the dividend payouts of Chennai Meenakshi Multispeciality Hospital Ltd and Shree Pacetronix Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.